Key result
Endothelial dysfunction in cerebral vascular disease requires combined tactical antioxidant and strategic cardioprotective therapy.
Answers are grounded in this paper and cite their sources.
The author evaluates a role of endothelium in the pathogenesis of cerebral vascular diseases (CVD) and considers the concept about endothelium as prevention and treatment of pathological processes leading to or triggering CVD. There are two medical strategies for correction of endothelium dysfunction in CVD: tactic (using of antioxidants) and strategic (statins, hypotensive drugs, antiaggregants).
No takes yet. Share an insight, caveat, or question.
M. V. Putilina (2017) conducted a review in Cerebral vascular diseases. Antioxidants, statins, hypotensive drugs, and antiaggregants was evaluated on Correction of endothelial dysfunction in cerebral vascular diseases. Endothelial dysfunction in cerebral vascular diseases can be targeted via 2 medical strategies: tactic (antioxidants) and strategic (statins, hypotensive drugs, antiaggregants).
Synapse has enriched 10 related papers. Consider them for comparative context: